Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Origins, biology, and diseases of tissue macrophages
Tissue-resident macrophages are present in most tissues with developmental, self-renewal,
or functional attributes that do not easily fit into a textbook picture of a plastic and …
or functional attributes that do not easily fit into a textbook picture of a plastic and …
Histiocytic disorders
KL McClain, C Bigenwald, M Collin… - Nature Reviews …, 2021 - nature.com
The historic term 'histiocytosis' meaning 'tissue cell'is used as a unifying concept for
diseases characterized by pathogenic myeloid cells that share histological features with …
diseases characterized by pathogenic myeloid cells that share histological features with …
Langerhans cell histiocytosis
C Rodriguez-Galindo, CE Allen - Blood, The Journal of the …, 2020 - ashpublications.org
Langerhans cell histiocytosis (LCH) is caused by clonal expansion of myeloid precursors
that differentiate into CD1a+/CD207+ cells in lesions that leads to a spectrum of organ …
that differentiate into CD1a+/CD207+ cells in lesions that leads to a spectrum of organ …
Vemurafenib for refractory multisystem Langerhans cell histiocytosis in children: an international observational study
J Donadieu, IA Larabi, M Tardieu, J Visser… - Journal of Clinical …, 2019 - ascopubs.org
PURPOSE Off-label use of vemurafenib (VMF) to treat BRAFV600E mutation–positive,
refractory, childhood Langerhans cell histiocytosis (LCH) was evaluated. PATIENTS AND …
refractory, childhood Langerhans cell histiocytosis (LCH) was evaluated. PATIENTS AND …
Histiocytosis
Histiocytoses constitute a heterogeneous group of rare disorders, characterised by
infiltration of almost any organ by myeloid cells with diverse macrophage or dendritic cell …
infiltration of almost any organ by myeloid cells with diverse macrophage or dendritic cell …
Langerhans-cell histiocytosis
Langerhans-Cell Histiocytosis A spectrum of diseases formerly known as histiocytosis X and
now called Langerhans-cell histiocytosis is characterized by ERK pathway activation …
now called Langerhans-cell histiocytosis is characterized by ERK pathway activation …
Langerhans cell histiocytosis in adults: advances in pathophysiology and treatment
M Kobayashi, A Tojo - Cancer science, 2018 - Wiley Online Library
Langerhans cell histiocytosis (LCH) is a rare systemic disorder characterized by the
accumulation of CD 1a+/Langerin+ LCH cells and wide‐ranging organ involvement …
accumulation of CD 1a+/Langerin+ LCH cells and wide‐ranging organ involvement …
A somatic mutation in erythro-myeloid progenitors causes neurodegenerative disease
The pathophysiology of neurodegenerative diseases is poorly understood and there are few
therapeutic options. Neurodegenerative diseases are characterized by progressive …
therapeutic options. Neurodegenerative diseases are characterized by progressive …
Histiocytoses: emerging neoplasia behind inflammation
J Haroche, F Cohen-Aubart, BJ Rollins… - The Lancet …, 2017 - thelancet.com
Histiocytoses are disorders characterised by inflammation and the accumulation of cells
derived from the monocyte and macrophage lineages, which results in tissue damage …
derived from the monocyte and macrophage lineages, which results in tissue damage …
Current understanding and management of pulmonary Langerhans cell histiocytosis
Pulmonary Langerhans cell histiocytosis (PLCH) is a diffuse lung disease that usually affects
young adult smokers. PLCH affects different lung compartments; bronchiolar, interstitial and …
young adult smokers. PLCH affects different lung compartments; bronchiolar, interstitial and …